Article Text

Download PDFPDF

Questions asked in the everyday practice: immune checkpoint inhibitors
  1. John B A G Haanen
  1. Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
  1. Correspondence to Dr John B A G Haanen; j.haneen{at}nki.nl

Abstract

Click here to listen tothe Podcast

  • podcasts

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.